Mary Kerr joins Advent Life Sciences as operating partner

Kerr started her new role on 23 September. She has also been appointed CEO of NeRRe Therapeutics, a biotechnology company funded by the firm.

Kerr joined Advent from GSK, where she had been senior vice president since 2012. She joined GSK in 2001, starting as vice-president. Kerr held a number of additional positions with the company, including European marketing director and global franchise head.

Since October 2009, she has been executive vice-president and head of the Europe region for ViiV Healthcare, which develops and produces medicine for HIV patients.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• UK / Ireland
• Advent Venture Partners